These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15345193)
1. Study of immune alterations in patients with chronic fatigue syndrome with different etiologies. Racciatti D; Dalessandro M; Delle Donne L; Falasca K; Zingariello P; Paganelli R; Pizzigallo E; Vecchiet J Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):57-62. PubMed ID: 15345193 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers. Maes M; Bosmans E; Kubera M Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326 [TBL] [Abstract][Full Text] [Related]
4. Chronic fatigue syndrome following a toxic exposure. Racciatti D; Vecchiet J; Ceccomancini A; Ricci F; Pizzigallo E Sci Total Environ; 2001 Apr; 270(1-3):27-31. PubMed ID: 11327394 [TBL] [Abstract][Full Text] [Related]
5. Immunological abnormalities in patients with chronic fatigue syndrome. Tirelli U; Marotta G; Improta S; Pinto A Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977 [TBL] [Abstract][Full Text] [Related]
11. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Peakman M; Deale A; Field R; Mahalingam M; Wessely S Clin Immunol Immunopathol; 1997 Jan; 82(1):83-91. PubMed ID: 9000046 [TBL] [Abstract][Full Text] [Related]
12. A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Brenu EW; Broadley S; Nguyen T; Johnston S; Ramos S; Staines D; Marshall-Gradisnik S J Immunol Res; 2016; 2016():9064529. PubMed ID: 26881265 [TBL] [Abstract][Full Text] [Related]
13. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202 [TBL] [Abstract][Full Text] [Related]